drugset / Trial / NCT03480997
Acute Bronchodilator Effect of Inhaled Albuterol Sulfate and Ipratropium Bromide in Patients With Stable COPD
Non-randomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to demonstrate the pharmacodynamic bioequivalence of the test product to the reference product as measured by increases in FEV1.
Timeline
- Start
- 2016-12-27
- Primary completion
- 2017-04-28
- Completion
- 2017-04-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ipratropium | Small molecule | 20 ug | Inhaled |
| Subject | Salbutamol | Unknown | 100 ug | Inhaled |
| Subject | Salbutamol | Unknown | 200 ug | Inhaled |